(Q53671736)

17 May 2018

title

Peripheral Neuropathy Due to Leprosy. (English)

1 reference

17 May 2018

0 references

Sharon P. Nations

1

1 reference

17 May 2018

Richard J. Barohn

series ordinal

2

1 reference

17 May 2018

publication date

1 May 2002

1 reference

17 May 2018

Current treatment options in neurology

published in

1 reference

17 May 2018

volume

4

1 reference

17 May 2018

issue

3

1 reference

17 May 2018

page(s)

189-196

1 reference

17 May 2018

https://scigraph.springernature.com/pub.10.1007/s11940-002-0035-z

exact match

0 references

cites work

An international randomized study with long-term follow-up of single versus combination chemotherapy of multibacillary leprosy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11940-002-0035-Z

Risk of relapse in leprosy after fixed-duration multidrug therapy

21 January 2018

1 reference

12 December 2020

ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors.

1 reference

12 December 2020

WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients

1 reference

12 December 2020

Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years

1 reference

12 December 2020

Current World Health Organization-sponsored studies in the chemotherapy of leprosy

1 reference

12 December 2020

Relapses after fixed duration multiple drug therapy: the AMFES cohort.

1 reference

12 December 2020

Steroid therapy for paralytic deformities in leprosy

1 reference

12 December 2020

Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients

1 reference

12 December 2020

Peripheral neuropathy in leprosy and its consequences.

1 reference

12 December 2020

Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results

1 reference

12 December 2020

The treatment of acute nerve function impairment in leprosy: results from a prospective cohort study in Bangladesh

1 reference

12 December 2020

Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis

1 reference

12 December 2020

The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up

1 reference

12 December 2020

The epidemiology of reactions and nerve damage

1 reference

12 December 2020

Relapses in multibacillary leprosy patients: effect of length of therapy

1 reference

12 December 2020

Results of a double blind study of the influence of thalidomide on the lepra reaction

1 reference

12 December 2020

Risk factors for erythema nodosum leprosum

1 reference

12 December 2020

Does clofazimine have a prophylactic role against neuritis?

1 reference

12 December 2020

Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL.

1 reference

12 December 2020

Surgery for neuritis in leprosy: indications for and results of different types of procedures

1 reference

12 December 2020

Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report

1 reference

12 December 2020

The management of erythema nodosum leprosum: current and future options

1 reference

12 December 2020

Experimental and Clinical Studies on Rifampicin in Treatment of Leprosy

1 reference

12 December 2020

A clinical prediction rule for nerve-function impairment in leprosy patients

1 reference

12 December 2020

A clinical trial of minocycline in lepromatous leprosy

1 reference

12 December 2020

Progression of eye disease in "cured" leprosy patients: implications for understanding the pathophysiology of ocular disease and for addressing eyecare needs

1 reference

12 December 2020

Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study).

1 reference

12 December 2020

Effect of prophylactic corticosteroids on the incidence of reactions in newly diagnosed multibacillary leprosy patients

1 reference

12 December 2020

Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.

1 reference

12 December 2020

An immunotherapeutic vaccine for multibacillary leprosy

1 reference

12 December 2020

Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum.

1 reference

12 December 2020

Rifampicin for lepromatous leprosy: nine years' experience

1 reference

12 December 2020

Reactional states and neuritis in multibacillary leprosy patients following MDT with/without immunotherapy with Mycobacterium w antileprosy vaccine

1 reference

12 December 2020

Effect of zafirlukast on leprosy reactions

1 reference

12 December 2020

10.1007/S11940-002-0035-Z

Identifiers

DOI

1 reference

17 May 2018

PubMed ID

11931725

1 reference

17 May 2018